Phibro Animal Health Secures #1 Buy Rank, 21.5% Growth in Low-PEG List
Phibro Animal Health earned a #1 buy rank and Value Score B after screening for stocks with below-industry-median PEG and P/E ratios, market cap over $1 billion and 5-year expected earnings growth of 21.5%. The selection places Phibro among four low-PEG picks targeted for value-driven portfolios.
1. Screening and Selection
Phibro Animal Health qualified for the low-PEG list after meeting multiple valuation criteria, including a PEG ratio below the industry median, a P/E ratio under the industry median, a #1 buy rank and Value Score B. It also boasts market capitalization exceeding $1 billion and average daily volume above 50,000 shares.
2. Company Profile
Headquartered in New Jersey, Phibro Animal Health Corporation provides animal health and mineral nutrition products for poultry, swine, beef, dairy cattle and aquaculture. The company also supplies specialized ingredients for personal care, automotive, industrial chemical and catalyst applications.
3. Growth Forecast and Implications
Analysts project a 5-year earnings growth rate of 21.5% for Phibro, reflecting its diversified revenue streams and strong demand for animal health solutions. Inclusion among four low-PEG picks highlights investor interest in value stocks offering above-average growth potential.